August 14, 2023

Paxlovid Study: Evaluates the treatment of Covid-19 in recently diagnosed children or teens with an underlying health condition that puts them at risk for severe illness.

You or your child must be a male or female aged 6 to 17 years of age with an underlying medical condition, positive for COVID-19, and experiencing symptoms. If you qualify for the study, you will be provided the medication to take for 5 days. The entire study will last approximately 1 month, with several clinic and in home visits. Blood samples will be collected throughout the study period. Compensation for participation is available. To learn more, visit or contact the UAB study team: 205-638-2629 or